Directed selection of MIP-1 alpha neutralizing CCR5 antibodies from a phage display human antibody library
- PMID: 9702779
- DOI: 10.1038/nbt0898-778
Directed selection of MIP-1 alpha neutralizing CCR5 antibodies from a phage display human antibody library
Abstract
The seven trans-membrane chemokine receptor CCR-5 is a coreceptor for macrophage tropic HIV-1 strains. CCR-5 responds to a number of chemokines, including macrophage inflammatory protein (MIP)-1 alpha. We describe the use of MIP-1 alpha in a biotin tyramine-mediated proximity selection to guide the selection of CCR-5-specific phage antibodies from a large phage display human library. Proximity based selections resulted in a population of antibodies recognizing CCR-5 on primary CD4+ lymphocytes, none of which blocked MIP-1 alpha binding to cells. The selected population of phage antibodies were subsequently used as guide molecules for a second phase of selection that was carried out in the absence of MIP-1 alpha. This generated a panel of CCR-5-binding antibodies, of which around 20% inhibited MIP-1 alpha binding to CD4+. The single chain Fvs (scFv) generated by this step-back selection procedure also inhibited MIP-1 alpha-mediated calcium signaling.
Similar articles
-
Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.J Mol Biol. 2001 Nov 9;313(5):1181-93. doi: 10.1006/jmbi.2001.5086. J Mol Biol. 2001. PMID: 11700073
-
Selection of active ScFv to G-protein-coupled receptor CCR5 using surface antigen-mimicking peptides.Biochemistry. 2004 Oct 5;43(39):12575-84. doi: 10.1021/bi0492152. Biochemistry. 2004. PMID: 15449947
-
Pharmacological characterization of the chemokine receptor, CCR5.Br J Pharmacol. 2002 Feb;135(4):1033-43. doi: 10.1038/sj.bjp.0704540. Br J Pharmacol. 2002. PMID: 11861332 Free PMC article.
-
Selection of antibodies against biotinylated antigens.Methods Mol Biol. 2002;178:147-57. doi: 10.1385/1-59259-240-6:147. Methods Mol Biol. 2002. PMID: 11968483 Review. No abstract available.
-
Panning of antibody phage-display libraries. Standard protocols.Methods Mol Biol. 2002;178:133-45. doi: 10.1385/1-59259-240-6:133. Methods Mol Biol. 2002. PMID: 11968482 Review. No abstract available.
Cited by
-
Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.J Biol Chem. 2013 Jul 5;288(27):19760-72. doi: 10.1074/jbc.M112.426288. Epub 2013 May 20. J Biol Chem. 2013. PMID: 23689510 Free PMC article.
-
CCR5 monoclonal antibodies for HIV-1 therapy.Curr Opin HIV AIDS. 2009 Mar;4(2):104-11. doi: 10.1097/COH.0b013e3283224015. Curr Opin HIV AIDS. 2009. PMID: 19339948 Free PMC article. Review.
-
Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.J Virol. 1999 May;73(5):4145-55. doi: 10.1128/JVI.73.5.4145-4155.1999. J Virol. 1999. PMID: 10196311 Free PMC article.
-
Engineering therapeutic antibodies targeting G-protein-coupled receptors.Exp Mol Med. 2016 Feb 5;48(2):e207. doi: 10.1038/emm.2015.105. Exp Mol Med. 2016. PMID: 26846450 Free PMC article. Review.
-
The role of phage display in therapeutic antibody discovery.Int Immunol. 2014 Dec;26(12):649-57. doi: 10.1093/intimm/dxu082. Epub 2014 Aug 18. Int Immunol. 2014. PMID: 25135889 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials